JY
AHPI

Jeff Yass’s Allied Healthcare Products AHPI Stock Holding History

Jeff Yass’s Portfolio AHPI Stock Details AHPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-12,655
Closed -$36K – 10674
2018
Q1 		$36K Buy
+12,655
New +$33.1K ﹤0.01% 9044

Other funds holding AHPI

OC
Oppenheimer & Close New York $159M AUM 49.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Jeff Yass's AHPI Position: Q2 2018 in Review

Jeff Yass sold out of Allied Healthcare Products (AHPI) in Q2 2018, closing a stake of 12,655 shares — an estimated $36K sold.

Jeff Yass first reported a position in AHPI in Q1 2018 and held it in 1 quarter. The position peaked at $36K in Q1 2018. 12 funds tracked by Wall St. Rank hold AHPI as of Q2 2018.

  • Jeff Yass reported no remaining Allied Healthcare Products position as of Q2 2018 after selling out during the quarter.
  • Jeff Yass sold 12,655 Allied Healthcare Products shares in Q2 2018, an estimated $36K.
  • Jeff Yass first reported a position in Allied Healthcare Products in Q1 2018 and held it in 1 quarter.
  • Jeff Yass's Allied Healthcare Products position peaked at $36K in Q1 2018.
  • 12 funds tracked by Wall St. Rank held Allied Healthcare Products as of Q2 2018.

Based on Susquehanna International Group's 13F filing for Q2 2018, filed 14 Aug 2018.